Article

Rapid <i>in silico</i> design of antibodies targeting SARS-CoV-2 using machine learning and supercomputing

2020-04-10

Abstract excerpt

<h4>Summary</h4> Rapidly responding to novel pathogens, such as SARS-CoV-2, represents an extremely challenging and complex endeavor. Numerous promising therapeutic and vaccine research efforts to mitigate the catastrophic effects of COVID-19 pandemic are underway, yet an efficacious countermeasure is still not available. To support these global research efforts, we have used a novel computational pipeline combin...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 4124bf38-f537-56ef-9978-19b6e7efa072
DOI: 10.1101/2020.04.03.024885

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Rapid <i>in silico</i> design of antibodies targeting SARS-CoV-2 using machine learning and supercomputingDOI 10.1101/2020.04.03.024885Read

Application of an integrated computational antibody engineering platform to design SARS-CoV-2 neutralizersSemantic proximity Read

AI-based antibody discovery platform identifies novel, diverse and pharmacologically active therapeutic antibodies against multiple SARS-CoV-2 strainsSemantic proximity Read

Design of nanobody targeting SARS-CoV-2 spike glycoprotein using CDR-grafting assisted by molecular simulation and machine learningSemantic proximity Read

High Throughput Designing and Mutational Mapping of RBD-ACE2 Interface Guide Non-Conventional Therapeutic Strategies for COVID-19Semantic proximity Read

Massively Multiplexed Affinity Characterization of Therapeutic Antibodies Against SARS-CoV-2 VariantsSemantic proximity Read

De novo design and Rosetta‐based assessment of high‐affinity antibody variable regions (Fv) against the SARS‐CoV ‐2 spike receptor binding domain ( RBD )Semantic proximity Read

Prediction and mitigation of mutation threats to COVID-19 vaccines and antibody therapiesSemantic proximity Read

Structure-Guided Design of Therapeutic Antibodies Targeting SARS-CoV-2 Omicron VariantsSemantic proximity Read

High-throughput ML-guided design of diverse single-domain antibodies against SARS-CoV-2Semantic proximity Read

SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution.Semantic proximity Read

Antibody drugs targeting SARS-CoV-2: Time for a rethink?Semantic proximity Read

Structure-guided mutations in CDRs for enhancing the affinity of neutralizing SARS-CoV-2 nanobody.Semantic proximity Read